Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Spain

MoH To Reimburse Latest Cancer Drugs

May 2007 | Industry News

The Spanish Ministry of Health has announced that it will reimburse most new oncology drugs approved by the European Medicines Agency (EMEA), after recent studies suggested that there was unequal access to the best treatments across the country. As a result,

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.

Related Insight Articles
Biotech Facing Financial, Regulatory Challenges

Companies / Spain According to Genoma Espana - a government-industry forum promoting Spain's biotechnology industry - venture capitalists remain wary of investing in local companies that are active in the field. The amount...
November 2006
Pfizer Laments Market Conditions

Companies / Spain As the Spanish government is set to introduce its new cost-cutting reforms to the country's pharmaceutical sector, Emilio Moraleda, the local chief of Pfizer, has lamented the outlook for the market....
October 2006
Antibiotic Resistance Worries Health Officials

Companies / Spain Spanish health officials are campaigning against the inappropriate use of antibiotics, amid signs that up to 30% of anti-infectives are routinely dispensed without a prescription, prompting fears of...
October 2006
Branded Drug Firms Attack Generics Rules

Companies / Spain Innovator drug companies operating in Spain have launched an attack on provisions regarding generic substitution in the new Medicines Law. Article 85 encourages pharmacists to substitute branded drugs...
October 2006
GSK Wins EU Parallel Trade Case

Companies / Spain The UK's GlaxoSmithKline (GSK) has won a landmark test case upholding the firm's right to restrict supplies to the Spanish market, in an attempt to halt undercutting in other markets by so-called parallel...
September 2006
Western Europe InsightWestern Europe Channels Western Europe Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2009 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS